Copyright
©The Author(s) 2023.
World J Diabetes. Jul 15, 2023; 14(7): 1057-1076
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1057
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1057
Figure 4 Targets related to Shuxin decoction for attenuating myocardial ischemia/reperfusion injury in diabetes.
A: Venn diagram of diabetes therapeutic targets in six disease databases; B: Venn diagram of myocardial ischemia/reperfusion injury (MI/RI) therapeutic targets in six disease databases; C: Venn diagram of diabetes related targets and MI/RI related targets; D: Venn diagram of the targets in at least two databases in C and the therapeutic targets of Shuxin decoction. MI/RI: Myocardial ischemia/reperfusion injury; SXT: Shuxin decoction; GEO: Gene Expression Omnibus.
- Citation: Yang L, Jian Y, Zhang ZY, Qi BW, Li YB, Long P, Yang Y, Wang X, Huang S, Huang J, Zhou LF, Ma J, Jiang CQ, Hu YH, Xiao WJ. Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes. World J Diabetes 2023; 14(7): 1057-1076
- URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1057.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i7.1057